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Abstract
The human CLCA4 (chloride channel regulator, calcium-activated) modulates the intestinal
phenotype of cystic fibrosis (CF) patients via an as yet unknown pathway. With the genera-
tion of new porcine CF models, species-specific differences between human modifiers of
CF and their porcine orthologs are considered critical for the translation of experimental
data. Specifically, the porcine ortholog to the human CF modulator gene CLCA4 has
recently been shown to be duplicated into two separate genes, CLCA4a and CLCA4b.
Here, we characterize the duplication product, CLCA4b, in terms of its genomic structure,
tissue and cellular expression patterns as well as its in vitro electrophysiological properties.
The CLCA4b gene is a pig-specific duplication product of the CLCA4 ancestor and its pro-
tein is exclusively expressed in small and large intestinal crypt epithelial cells, a niche spe-
cifically occupied by no other porcine CLCA family member. Surprisingly, a unique
deleterious mutation of the CLCA4b gene is spread among modern and ancient breeds in
the pig population, but this mutation did not result in an apparent phenotype in homozy-
gously affected animals. Electrophysiologically, neither the products of the wild type nor of
the mutated CLCA4b genes were able to evoke a calcium-activated anion conductance, a
consensus feature of other CLCA proteins. The apparently pig-specific duplication of the
CLCA4 gene with unique expression of theCLCA4b protein variant in intestinal crypt epithe-
lial cells where the porcine CFTR is also present raises the question of whether it may mod-
ulate the porcine CF phenotype. Moreover, the naturally occurring null variant of CLCA4b
will be valuable for the understanding of CLCA protein function and their relevance in modu-
lating the CF phenotype.
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Introduction
Proteins of the chloride channel regulator, calcium activated (CLCA) family are putative mod-
ulators of the cystic fibrosis (CF, mucoviscidosis) phenotype, a lethal inherited disease caused
by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene [1–4].
These gene defects result in its functional loss as a chloride and bicarbonate channel, conse-
quently leading to mucus plugging in various organs including the respiratory and intestinal
tracts, with the hallmark lesion being a secondary bacterial lung infection [5]. The CF pheno-
type differs widely in severity between patients despite identical CFTRmutations. Disease out-
come, quality and expectancy of life vary remarkably even between siblings bearing the same
genetic defect [6,7]. In addition to environmental factors, various genetic modifiers of the dis-
ease have been suspected to account for this variability [7]. Among these putative modulators
is an alternative chloride current which has been proposed to at least partially compensate for
the loss of the CFTR-mediated chloride secretion in CF tissues [8–10].
The human CLCA members CLCA1 and CLCA4 are expressed in CF-relevant tissues and
their allelic variants have been identified as modulators of the intestinal residual anion conduc-
tance in CF patients [1,3,4,11,12]. In contrast to earlier conceptions, the proteins do not form
ion channels themselves but appear to modulate calcium-dependent chloride conductances
probably as a modifier of TMEM16A activity [13–16].
The modulatory role of CLCA proteins has been confirmed in mouse models of CF. The
intestinal phenotype of CF mice is ameliorated by experimental overexpression of Clca1 (for-
merly known as mClca3, now renamed according to nomenclature in humans) [2]. The murine
Clca4a (formerly known as mClca6) is a known inducer of a calcium-activated chloride con-
ductance and its protein co-localizes with that of the murine CFTR in enterocytes [17,18].
However, all murine models of CF have important drawbacks limiting their usefulness in trans-
lational research on CF and CLCA proteins. In terms of CF, none of the murine models avail-
able reflects the complexity of the human CF phenotype, primarily due to their lack of the
characteristic respiratory pathology [19]. Furthermore, drastic differences exist between the
human and murine CLCA gene loci, with four CLCA genes in humans and eight in mice [20].
Moreover, the human CLCA3 is thought to represent a pseudogene, in contrast to its murine
counterparts Clca3a1, -3a2 and -3b (formerly known asmClca1, -2, -4) [21]. Another impor-
tant difference is the variance between the cellular expression patterns of the murine Clca4a
and its human ortholog CLCA4 [17].
In contrast to murine CF models, the newly generated CF pigs develop all hallmark features
of the human disease including respiratory pathology with mucus overproduction and second-
ary bacterial pneumonia. Thus, CF pigs are expected to become the more relevant animal
model in CF research [22–27].
Considering both the potential of the porcine CF model and the role of CLCA gene products
in CF, we have started to characterize the CLCA gene family in the pig, particularly focusing on
possible differences between pigs, humans, and mice [28–30]. Although our data have revealed
essential similarities between porcine and human CLCA genes and their proteins, a species-
specific gene duplication of the porcine CLCA4 ortholog was found, resulting in CLCA4a and
CLCA4b [28] with the former being recently characterized in detail [29].
Here, we describe genetic characteristics, the tissue and cellular expression patterns and the
in vitro calcium-activated chloride conductance signature of CLCA4b. One entirely unexpected
finding of this study was the discovery of naturally occurring CLCA4b gene silencing in a large
subset of the porcine population, resulting in complete lack of the protein with no obvious
phenotype.
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Material and Methods
Genetic Characterization
Exon/intron structures, the coding region as well as the amino acid sequence of CLCA4b were
identified using BioEdit as described, by using the porcine CLCA4a, the human CLCA4 and the
murine Clca4a as reference genes [28,31]. In order to identify potential regulatory properties of
the CLCA4b upstream region, sequences between CLCA4 genes and the upstream located gene
CLCA1 and downstream located CLCA3 from 12 different mammalian species (human,
macaque, marmoset, mouse, rat, cat, dog, panda, horse, cattle, alpaca, and dolphin) as well as
the intergenic regions of porcine CLCA1 and CLCA4a, CLCA4a and CLCA4b as well as
CLCA4b and CLCA3 were obtained from the ensemble database (www.ensembl.org) and
aligned using Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Potential conserved
binding sites for transcription factors were determined by Genomatix ElDorado/Gene2Promo-
ter and GEMS Launcher software packages (Genomatix,Munich, Germany), according to
Wünsch and colleagues [32]. Repetitive elements identified by RepeatMasker (http://www.
repeatmasker.org) were excluded from the analysis. Upstream regions of CLCA4a and
pCLCA4b were compared to human and bovine genomic regions by BLASTn (http://blast.ncbi.
nlm.nih.gov/Blast.cgi). To evaluate evolutionary forces on the CLCA4 genes, the coding
sequences from man, macaque, rat, mouse, horse, cat, dog, sheep, and cattle CLCA4 as well as
those from porcine CLCA4a and CLCA4b were compared in a multiple sequence alignment.
Conserved protein domains were identified by BLASTp (http://blast.ncbi.nlm.nih.gov/Blast.
cgi) and putative sites prone to positive selection were identified by the codonML software
from the PAML package (http://abacus.gene.ucl.ac.uk/software/paml.html). Phylogenetic trees
were calculated as described [33].
Animals, Tissue Processing and Ethical Statement
Tissues from six-week-old male EUROC x Pietrain pigs (n = 5 from one litter) as well as the
genital tracts of two- or three- months-old female mixed breed pigs (n = 2) were used to study
the expression pattern of pCLCA4b on RNA level using RT-PCR and on protein level using
immunohistochemistry as described [29]. Mixed breed pigs were screened for the mutation on
genomic level as described below. In addition, porcine samples of the colon and jejunum from
pigs were snap frozen or fixed in 4% formalin for expression analyses on RNA and protein
level, respectively. All experiments were approved according to the rules of the German Animal
Welfare Law by the ethical committee of the local governmental authorities (State Office of
Health and Social Affairs Berlin, approval IDs: O 0401/12 and T 0400/12). The pigs were
housed in groups in the ruminant and swine clinic of the Veterinary Department of Freie Uni-
versität Berlin which is a veterinary surgery training institute approved by the European Asso-
ciation of Establishments for Veterinary Education (EAEVE). The surgery to neuter pigs was
performed under ketamine and azaperone anesthesia, and all efforts were made to minimize
suffering. Euthanasia, if applicable, was performed by intravenous or intracardial application
of embutramide in deep ketamine/azaperone anesthesia. Surgeries and euthanasia which took
place at the ruminant and swine clinic of the Veterinary Department of Freie Universität Berlin
were conducted by a veterinarian.
Genotyping of Animals
Genomic DNA was isolated from testicles obtained during neutering animals, from ear marking
biopsies or skin from routinely autopsied pigs by addition of 100 μl isolation buffer (2 M Tris
pH 8.5, 0.5 M EDTA, 10% SDS, 5 M NaCl) with 12 μl proteinase K (10mg/ml; Carl Roth GmbH
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& Co. KG, Karlsruhe, Germany). The samples were incubated at 55°C for 3 hrs, followed by
incubation at 95°C for 10 min. Subsequently, 800 μl TE/RNase A mix (0.5 M EDTA pH 8.0, 1 M
Tris pH 7.6, 10 mg/ml RNase A) were added to each sample. After a final heating at 99°C for 15
min, the samples were frozen at -20°C until further use. In addition, whole genomic DNA from
ten different porcine breeds (Mangalitsa, Hampshire, Large White, Cerdo Iberico, Pietrain,
Duroc, Swabian, Large Black, German Landrace, Turopolja; n = 3 to 5 per breed) were geno-
typed for the presence of the mutation. To distinguish between pigs carrying the mutation and
wild type animals, a restriction endonuclease assay was established on a specific genomic DNA
amplicon. In a first step, PCR products of the genomic DNA containing the deletion were
amplified using primers 5’-ACACCTGATAAGTAATGCCCTGGA-3’ (upstream) and 5’-
CCGCATTTGGCCCGAGAGCA-3’ (downstream) according to the following protocol: 30
cycles at 95°C for 2 min, 95°C for 30 sec, 64°C for 30 sec and 72°C for 15 sec with a final exten-
sion at 72°C for 10 min. Second, DraI (FastDigest, Fermentas, St. Leon-Rot), recognizing the
DNA site 5'-. . .TTT#AAA. . .-3', cleaved the amplicon of genomic CLCA4b DNA only in case
of the genomic deletion. In contrast, Tsp509I (FastDigest, Fermentas, St. Leon-Rot), cutting at
5'-. . .#AATT. . .-3', only processed the amplicon of non-mutated genomic CLCA4b DNA. Each
of the samples was additionally tested using primers discriminating mutated genomic DNA
against wild type genomic DNA (Table 1) and / or complete sequencing.
Cloning and Sequencing of the CLCA4bGene
Total RNA isolated from the colon of three different pigs was reverse transcribed with SuperScript
III First-Strand Synthesis System (Invitrogen, Karlsruhe, Germany) as described [28]. The open
reading frame (ORF) of CLCA4b (Plog et al. 2009; GenBank accession nos. XM_003125934.2 and
CU469041.5) was amplified using the primers 5’-GAAAAGCCTCTTGAACAAG-3’ (upstream)
and 5’-ACCTAAATATCCATTCTAGATT-3’ (downstream) and High Fidelity Taq polymerase
(Fermentas, St. Leon-Rot, Germany) as follows: 30 cycles at 94°C for 3 min, 94°C for 30 sec,
49.3°C for 30 sec, 72°C for 3 min, 72°C for 10 min with a time increment of 2 sec per cycle. The
coding sequences with and without the deleterious mutation were cloned into pcDNA3.1 by T-
addition as described [28]. With exception of the mutation, 100% sequence identity was con-
firmed via complete sequencing. In addition, the amplified cDNA of three different pigs bearing
the mutation was sequenced for verification purposes without subsequent cloning.
Sequence Characterization and Generation of Antibodies
In silico analyses of the pCLCA4b amino acid sequence and the generation of antisera against
pCLCA4b were performed as described [28,29]. In brief, rabbits were immunized with the






ND primers used for ampliﬁcation of genomic CLCA4b without sequence deletion with an amplicon length of 192 bp. Protocol: 95C/ 2 min, 95C / 30 sec,
60C /30 sec, 72C / 6 sec, 72C / 10 min, 30 cycles
D primers used for ampliﬁcation of genomic CLCA4b with sequence deletion with an amplicon length of 186 bp. Protocol: 95C / 2 min, 95C / 30 sec, 60C /
30 sec, 72C / 6 sec, 72C / 10 min, 30 cycles
doi:10.1371/journal.pone.0140050.t001
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following oligopeptides located within the amino-terminus of the pCLCA4b protein (p4b-N-1;
HFYTTDQSESRGLT; corresponding to amino acid positions aa 455–468, and p4b-N-2; KLI-
QIKSNNERRKL; corresponding to amino acids 356–369). The obtained antisera were tested
via immunoblotting for specificity as described below, and serum p4b-N-1 was found most
suitable for immunoblotting and immunohistochemistry whereas p4b-N-2 only succeeded in
immunoblotting experiments using CLCA4b-transfected cells.
Transient Transfection of HEK293 Cells and Immunoblotting
HEK293 cells were transiently transfected with the CLCA4b ORF cloned into pcDNA3.1 and
processed for immunoblotting as described [28,29]. Snap frozen whole tissue sections or
scraped mucosa of small and large intestine were homogenized using a Precellys 24 (peqlab
Biotechnologie GmbH, Erlangen, Germany).
Immunoblot analyses were performed as described using the anti-pCLCA4b antibodies
p4b-N-1 (1:5,000) or p4b-N-2 (1:5,000) [28]. The corresponding preimmune sera (1:5,000) or
absorbed p4b-N-1 serum (with 20 μg/ml of its specific peptide or with an irrelevant peptide)
served as negative controls.
mRNA and Protein Expression Patterns in Tissues
Total RNA was isolated as described [27]. Specific CLCA4b primers were designed using
Primer BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to amplify a 172 base pairs
product (5’-CAGGCTGCTGGAAAAGCAAAAACTG-3’; 5’-CAGACGCTATTCTGGT
GAAACTCTC-3’). PCR amplification using DreamTaq DNA Polymerase (Fermentas,
St. Leon-Rot, Germany) included 34 cycles at 95°C for 2 min, 95°C for 30 sec, 70.5°C for 30 sec
and 72°C for 30 sec with a final extension at 72°C for 10 min. Representative amplicons from
small intestine, large intestine and nasal mucosa were additionally sequenced and tested via
BLASTn (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to confirm 100% sequence identity with
CLCA4b. All experiments were repeated at least twice. The mRNA quality and efficacy of
reverse transcription were tested as described [29]. To exclude cross reactivity with any of the
other porcine CLCA members, PCR reactions were carried out using the cloned ORFs of
CLCA1 [28], CLCA2 [30], or CLCA4a [29] as templates. cDNA of jejunal or colonic samples
from homozygous wild type (n = 3), homozygous mutated (n = 5) or heterozygous (n = 4) pigs
was subsequently used as template in a quantitative RT-PCR analysis using Maxima Probe
qPCRMasterMix (Fermentas). Primers, taqman probes and protocols are listed in Table 2. Tar-
get gene expression was quantified as described [17].
Table 2. Primers used for quantitative RT-PCR investigation.
Primer & probes Sequence
p4b-For-qPCR 5’-AGTGAAACAAAGTGGGGCCATC-3’
p4b-Rev-qPCR 5’-GAAATGCATCCCTCCTGTTACGG-3’
p4b taqman probe 5’-CTATTGCTCTCGGGCCAAATGCGGACC-3’
EF-1a-For-qPCR 5’-AGAACATGATTACAGGCACTTCCC-3’
EF-1a-Rev-qPCR 5’-GGAAATACCTGCTTCGAATTCACC-3’
EF-1a taqman probe 5’-ACCAGCAGCAACAATCAGGACAGCACA-3’
p4b primer & probes: Amplicon length100 bp. Protocol: 95C / 3 min, 95C / 10 sec, 61,4C / 30 sec, 40 cycles
EF-1a primer & probes: Amplicon length 86 bp. Protocol: 95C / 3 min, 95C / 10 sec, 61.4C / 30 sec, 40 cycles
doi:10.1371/journal.pone.0140050.t002
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For immunohistochemical protein localization in cells and tissues, formalin-fixed, paraffin-
embedded tissues were processed as described [33] using anti-CLCA4b antibody p4b-N-1, pre-
immune sera or the antibody preincubated with 50 μg/ml of its specific peptide. Antibody dilu-
tions ranged from 1:500 to 1:10,000 with optimal results at 1:8,000. In addition, consecutive
slides were stained with specific antibodies against CLCA1 [28] or CLCA2 [30] in mutated and
wild type pigs, respectively. Cryostat sections were used for expression analysis of CLCA4a
[29]. Consecutive sections were also analyzed histopathologically using standard hematoxylin
& eosin (H&E) staining.
In vitro Electrophysiology
In vitro electrophysiological assays were conducted as described [34] with the equine CLCA1
clone as positive control for induction of a calcium-activated chloride current. The cDNA of
the two different CLCA4b clones (CLCA4b wt, CLCA4bmut) or CLCA1 was co-transfected
with EGFP or RFP cDNA into HEK293 cells (American Type Culture Collection, Manassas,
VA USA) using Lipofectamine 2000 Transfection Reagent (Invitrogen, Carlsbad, CA USA).
CLCA-expressing cells were targeted for whole-cell recordings based on EGFP or RFP fluores-
cence 12–24 hours after transfection. Whole cell recordings were obtained using patch elec-
trodes pulled from borosilicate glass (1.2 mm OD, 0.95 mm ID, with an internal filament) with
a Narishige PC-10 vertical pipette puller. The resistance was 8–12 MO when the pipettes were
filled with an internal solution containing (in mM) 98 KCH3SO4, 44 KCl, 3 NaCl, 3 MgCl2, 1
CaCl2, 3 EGTA, 5 HEPES, 2 glucose, 1 Mg-ATP, 1 GTP-Na, 1 reduced glutathione (pH = 7.8,
osmolarity = 287 mOsm). Cells were constantly superfused at ~1 ml/min with an oxygenated
extracellular solution containing (in mM) 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10
glucose (pH = 7.4, osmolarity = 290–295 mOsm) and voltage-clamped at -50 mV using an
Axopatch 200B amplifier (Axon Instruments/Molecular Devices; Sunnyvale, CA). Test pulses
were delivered and currents were acquired using pClamp 9.2 with a Digidata 1322 interface
(Axon Instruments/Molecular Devices). Ionomycin, a calcium ionophore used to stimulate an
increase in intracellular [Ca2+], was diluted 1:1,000 to an extracellular working solution con-
centration of 10 μM from a stock prepared in DMSO. The Ca2+-evoked current-voltage (I-V)
relationship was measured as the difference of the currents recorded in response to a series of
voltage steps (150 ms, -110 to -10 mV) before and after ionomycin application. The reversal
potential of the ionomycin-evoked current was determined by linear extrapolation. Experi-
ments were conducted at room temperature. With these recording solutions, ECl was predicted
to be -25 mV. All chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA) except
for KCH3SO4 which was obtained from Pfaltz and Bauer (Waterbury, CT, USA) and ionomy-
cin which was obtained from Tocris (Ellisville, MO USA).
Statistical Analysis
All data are presented as mean ± SEM. Statistical comparisons were performed using Student’s
t-test. A P value of< 0.05 was considered to be statistically significant.
Results
Porcine CLCA4b is a unique duplication of CLCA4a and a naturally
occurring deletion mutant of CLCA4b exists in the porcine population
The duplication of the CLCA4 gene into CLCA4a and CLCA4b appears to be a unique event in
the pig and has not been observed in any other species analyzed so far [28]. A systematic analy-
sis revealed an overall highly similar genetic structure to CLCA4a, albeit with longer intron
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sequences (Fig 1A). Like CLCA4a and other mammalian CLCA4 genes [29], CLCA4b is also
composed of 14 exons and the protein is only six amino acids shorter than pCLCA4a, due to a
single amino acid deletion in exon 2 and a second deletion of 5 amino acids in exon 14. To
determine the evolutionary history of the porcine CLCA4 duplication, the genomic region
between CLCA1 and CLCA3 genes which contain CLCA4a and CLCA4b in the pig and CLCA4
in all other examined mammalian species were compared (Fig 1B). Throughout the entire
length of 29 kb, the region between CLCA1 and CLCA4a showed high homology with the cor-
responding regions in humans and cattle. The downstream region of the CLCA4a gene showed
similarity to the corresponding regions between mammalian CLCA4 and CLCA3 genes for 11.6
kb, but then in the pig a region follows that lack any similarity to other mammalian CLCA loci
and rather comprises repetitive elements. Further downstream of porcine CLCA4a, only a
short region of 0.5 kb, quite upstream of the CLCA4b transcription start site, showed similarity
to the region upstream of the bovine CLCA4, suggesting that CLCA4b resulted from a duplica-
tion of an initial porcine CLCA4 ancestor gene. Thus, while CLCA4a comprises the original
gene with the entire regulatory elements of the ancestor, the regulatory properties of CLCA4b
might have been altered as a result of the duplication. Although we have found numerous
potential binding sites for transcription factors (TFB) in the upstream region of pCLCA4b, the
length of this potential proximal promoter is much shorter than the conserved putative pro-
moters of other mammalian CLCA4, including porcine CLCA4a. On the other hand, putative
unique enhancer elements of porcine CLCA4b were identified as conserved and potential regu-
latory elements that are otherwise located downstream of CLCA4 in other mammalian species
are positioned upstream of the porcine CLCA4b as a result of the gene duplication.
As the assembly of novel regulatory properties might have resulted in a speciation of the
two porcine CLCA4 genes, we evaluated whether a change in evolutionary pressure took place
after gene duplication. Assuming that evolutionary adaptation may preferentially take place at
sites prone to positive selection in the mammalian CLCA4 genes, we analyzed the accumulation
of unique sites in the CLCA4a and 4b protein in these regions (Fig 1C). Within the otherwise
highly conserved N-domain, the van Willebrand-factor A domain and a domain of unknown
function (DUF), we identified positions which may be under positive selection. Among those,
a region of 160 amino acids, constituting a proportion of the van Willebrand-factor A domain
and the adjacent downstream region, is highly conserved among the examined species. How-
ever, 18 positions yield evidence of positive selection. 38 amino acids within this stretch are
unique for the pCLCA4b protein (23.7%) whereas the amount of unique amino acids in the
other examined CLCA members is only between 3 and 21 (8.7 ± 5.6). Additionally, of the 18
positions under positive selection, 15 show differences between the CLCA4a and CLCA4b pro-
teins. Thus, the maintenance of a full-length open reading frame of the CLCA4b gene in the
GenBank database sequences as well as its slight but specific evolutionary differences suggest
functional adaptation as a result of the genetic duplication.
In contrast to these findings, however, there was occasional evidence of a 10 bp deletion in
CLCA4b, involving the 5´-end of exon 8 as well as the upstream intronic region (Fig 2), result-
ing in the loss of the splice site acceptor site of intron 7. As a consequence, variations of alterna-
tive splicing of the CLCA4b transcripts were observed in pigs bearing this naturally occurring
mutation (Fig 2). While transcripts from wild-type CLCA4b showed the predicted nucleotide
sequence with a coding sequence (cds) of 2,766 bp, alternative splicing to an AG-site 38 bp
upstream of exon 8 resulted in an insertion of 28 bp into the transcript that causes a frame shift
and generates a premature termination codon (PTC) within exon 8 (Fig 2, cds mut 1). Alterna-
tively, splicing out exon 8 (178bp) resulted in a frame shift and a PTC within exon 9 (Fig 2, cds
mut 2). Occasionally, outsplicing of exon 8 concurrently occurred with an alternative splicing
to exon 4, introducing a sequence of 105 bp to the cds (Fig 2, cds mut 3), and again causing a
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Fig 1. Comparison of the genomic structures of CLCA4a andCLCA4b, their promoter regions and the encoded proteins sequences. (A) Albeit
having longer intronic sequences thanCLCA4a (top panel), the genomic structure of CLCA4b (bottom panel) was highly similar to its paralog with the same
number of exons (boxes) and has an open reading frame according to its ortholog. Due to a deletion of one amino acid in exon 2 and a gap of 5 amino acids
in exon 14 the translated CLCA4b protein is slightly shorter than the CLCA4a protein with 921 vs. 927 amino acids (aa). (B) The intergenic region between
CLCA1 andCLCA4a showed high homology to the orthologous bovine and human regions (top panel). In the intergenic region betweenCLCA4a and 4b,
only the sequence downstream toCLCA4a showed homology to the corresponding bovine and human regions (I) followed by a sequence with no similarity to
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deleterious modification of the transcript. However, such transcript variant was only found in
a single individual and we did not further examine whether this finding was specific for the
mutated variant or a common effect of CLCA4b.
We then attempted to estimate the prevalence of the 10 bp genomic deletion in the porcine
population and in certain breeds. Genomic DNA of various pure- and mixed-breed pigs was
analyzed using the restriction endonucleases DraI and Tsp509I to distinguish between mutated,
wild type and heterozygous individuals. In a total of 103 pigs, we found incidence for underrep-
resentation of wild-type alleles (16.5%) compared to pigs bearing the mutation on both alleles
(39.8%) or on a single allele (43.7%; Table 3), but the dominance of pigs from commercial meat
production units might have biased this statistical analysis. More specifically, we identified
breeds that either lacked the wild-type allele (Duroc) or the mutated allele (Large White, Cerdo
Iberico), but the low number of animals from those breeds compromises statistically reliable
conclusions.
any sequence of mammalian CLCA loci investigated (II). In contrast, the region proximal to CLCA4b had homology to the intergenic region upstream from the
human and bovineCLCA4 gene (III) (bold style: regions with similarity to both species, faint style: regions without similarity to any of the species, boxes:
repetitive elements). In regions I and III, parts are conserved among the examined mammalian species and contain numerous putative transcription factor
binding sites (TFB). Sequences not fully conserved at TFB sites in distinct species are shaded; sequences not matching the prerequisites of the binding sites
in distinct species are densely shaded. C) Alignment of 11 protein sequences clustering to the CLCA4 family revealed three conserved domains, the
CLCA_N domain, the vanWillebrand-factor A domain and a domain of unknown function (DUF). Sites of positive selection were defined by the codonML
software, using the model algorithms 3 (discrete, naïve empirical bayes) and 8 (beta & omega > 1, naïve empirical bayes). Sites that are proposed to be
positively selected are marked with a rhombus, sites that are proposed as significantly (p > 95%) or highly significantly (p > 99%) positively selected in both
algorithms have two or three rhombi, respectively. In comparison, positions that are unique for CLCA4a or CLCA4b are labeled with triangulars or circles,
respectively. A conserved region covering parts of the vWFA domain as well as the downstream sequence is shown in detail. Of the 38 unique sites in
pCLCA4b in this region, 15 are located at sites under putative positive selection.
doi:10.1371/journal.pone.0140050.g001
Fig 2. A deletionmutation in theCLCA4b gene leads to transcripts with a premature termination codon. A 10 base pair (bp) deletion was found at the
splice acceptor site of exon (ex) 8. The mutated gene (mut) coded for different alternatively spliced mRNA species (cd smut 1 to 3) with an insertion (grey
box), loss of exon 8 (grey cross) or the insertion (grey box) and loss of exon 8 (grey cross). All alternatively spliced transcripts had a premature termination
codon (PTC) with shortened predicted ORFs.
doi:10.1371/journal.pone.0140050.g002
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Generation and specificity of anti-CLCA4b antibodies
In silico analyses of the CLCA4b amino acid sequence using several prediction programs sug-
gested a transmembrane domain between aa 882 and 908, with a carboxy-terminal intracellular
domain and an amino-terminal extracellular tail (Fig 3A).
Total cell lysates from pCLCA4b-transfected HEK293 cells or whole intestinal tissue lysates
were immunoblotted with antibody p4b-N-1 diluted 1:5,000. The antibody clearly recognized a
140 kDa protein, consistent with the canonical CLCA-precursor protein, and a 120 kDa pro-
tein, consistent with its amino-terminal cleavage product (Fig 3B). Both bands were absent
when the preimmune serum was used. Moreover, the two bands disappeared when the anti-
body was preabsorbed with its specific peptide (Fig 3B). Preincubation of the antibody with an
irrelevant peptide instead of the specific peptide in the same concentration revealed no changes
in signal intensity. Cells transfected with the pcDNA3.1 vector alone (mock) served as negative
control. Thus, the CLCA4b protein was processed according to the well-characterized path of
other CLCA proteins, including post-translational cleavage of the precursor protein [20].
Antibody specificity was further confirmed by immunoblotting analysis of HEK293 cell that
have been transfected with expression constructs of any other known porcine CLCA members
(CLCA1, CLCA2, CLCA4a). Whereas CLCA proteins were successfully detected by using the
respective antibodies, neither p4b-N-1 nor p4b-N-2 did detect specific bands in any of those
cases (Fig 3C and 3E).
In contrast to the wild-type CLCA4b, no specific bands were detected when lysates of
HEK293 cells transfected with a vector expressing the mutated form of pCLCA4b (Fig 3C).
This was particularly true for antibody p4b-N-2 that was designed to also detect the truncated
form of CLCA4b (Fig 3D and 3E).
Tissue expression pattern of the CLCA4b protein and phenotyping of
CLCA4bmutant pigs
To elucidate the tissue and cellular expression pattern of CLCA4b, antibody p4b-N-1 was used
for immunohistochemical protein localization in various formalin-fixed, paraffin-embedded
tissues. In pigs carrying the wild-type form of the gene, the CLCA4b protein was exclusively
detected in apical membranes of small and large intestinal crypt epithelial cells (Fig 4A) but
not in any other tissue. The specificity of this signal was confirmed by pre-incubation of the
Table 3. Incidence of CLCA4bwild type, mutant and heterozygous pigs in various porcine breeds.
Breed No. of individuals Wild type Mutant Heterozygous
Mangalitsa 4 2 2 -
Hampshire 3 - - 3
Large White 3 3 - -
Cerdo Iberico 3 3 - -
Pietrain 3 - 1 2
Duroc 3 - 3 -
Swabian 3 1 - 2
Large Black 3 2 - 1
German Landrace 5 2 1 2
Turopolja 3 - 1 2
Mixed breed (EUROC x Pietrain) 5 1 1 3
Mixed breed (unknown cross-breeding) 65 3 32 30
Total 103 17 (16.5%) 41 (39.8%) 45 (43.7%)
doi:10.1371/journal.pone.0140050.t003
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Fig 3. Both antibodies against the amino-terminus ofCLCA4b detect two specific bands inCLCA4b
transfected cell lysate. (A) Two antibodies against CLCA4b were generated, both against peptides
corresponding to the proposed amino-terminal cleavage product of the protein. The length and mass of the
theoretically truncated protein CLCA4b were calculated, and antibody p4b-N-2 was designed to also
recognize a truncated CLCA4b protein in the immunoblot. SS = signal sequence; TMD = transmembrane
domain; C = carboxy-terminus; N = amino-terminus. (B) Antibody p4b-N-1 recognized an approx. 140 kDa
precursor protein as well as a 120 kDa amino-terminal cleavage product in the cell lysate of HEK293 cells
transiently transfected with the CLCA4b ORF in pcDNA3.1 (left). No specific bands were detected when cells
were transfected with the pcDNA3.1 vector alone (mock). Preabsorption of antibody p4b-N-1 using 20 μg/ml
of its specific peptide resulted in complete abolishment of the specific bands (right pattern). (C) Antibody p4b-
N-1 failed to detect any specific bands in cell lysates of cells transfected with other porcine CLCA family
members, CLCA1, CLCA2 or CLCA4b. In cells transfected with the CLCA4b clone carrying the additional
intron sequence due to the genomic deletion (CLCA4b mut), no specific protein bands were detected,
arguing for a complete inhibition of protein translation in these cells. In comparison, both the precursor protein
and the amino-terminal cleavage product are clearly visible when cells were transfected with the intact
CLCA4b clone without a deletion (CLCA4b wt). (D) The results of the antibody p4b-N-1 were confirmed by
antibody p4b-N-2 which recognized two band of the same size in cell lysates from HEK293 cells transiently
transfected with the CLCA4b ORF in pcDNA3.1 (left pattern). No specific bands were detected in lysates from
mock transfected cells. Preimmune serum served as negative control and failed to reveal any specific bands
(right pattern). (E) No specific bands were detected by antibody p4b-N-2 when cells transfected with CLCA1,
CLCA2, or CLCA4a clones were subjected to immunoblotting. Interestingly, although this antibody would be
capable of detecting a possibly shortened CLCA4b protein, no specific bands were detected in cell lysates
from cells transfected with the CLCA4b (mut) clone, arguing for a complete translation stop of the CLCA4b
protein in case of the mutation.
doi:10.1371/journal.pone.0140050.g003
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antibody with its specific peptide and the use of the preimmune serum which both resulted in
complete loss or strong reduction of the signal.
In animals bearing the mutated form of the CLCA4b gene on both alleles, protein was nei-
ther found in the small nor in the large intestine nor in any other organ (Fig 4A). Remarkably,
in heterozygous animals, we found a strong and consistent CLCA4b protein signal in the small
intestine (Fig 4A), but the protein was fully absent in any of the large intestinal compartments.
Fig 4. TheCLCA4b protein is exclusively located in apical membranes of intestinal crypt epithelial
cells and shows high variations in response to the genomic deletion ofCLCA4b. (A) In wild type pigs
without the genomic deletion of CLCA4b, the protein is invariably located at apical membranes of non-goblet
and goblet cells in the crypts of the small (upper left) and large (lower left) intestines. In heterozygous pigs,
the protein is similarly distributed in the small intestine (upper central) whereas it is completely absent from
the large intestine (lower central). In pigs with the genomic deletion of CLCA4b, no CLCA4b protein was
detected, neither in the small (upper right) nor in the large intestine (lower right). Immunohistochemistry using
antibody CLCA4b-N-1 diluted 1:8,000. Bars: 80 μm. (B) Quantitative RT-PCR expression analysis from
jejunum (black) and colon tissues (white) revealed CLCA4b expression twice as high in the jejunum than in
the colon of CLCA4b wild type pigs (left). When compared to wild type pigs, CLCA4b mutant pigs (right
pattern) had a markedly decreased amount of CLCA4b mRNA in both the jejunum and colon. While CLCA4b
mRNA copy numbers were also reduced in the colon of heterozygous compared to wild type pigs, copy
numbers of CLCA4b in the jejunum were markedly increased (central pattern). Results are mean +/- SEM.
doi:10.1371/journal.pone.0140050.g004
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Immunohistochemical and histopathological analyses of intestinal tissues of homozygous
wild type (n = 2) and homozygous mutant pigs (n = 4) did not indicate any differences in
CLCA1, -2 or -4a protein expression or any structural or pathological differences as a result of
the CLCA4b genotype.
The mRNA expression pattern investigated by conventional RT-PCR confirmed these
results, showing strong and consistent specific signals for the intestinal tract only. Weak signals
of the CLCAb transcripts were obtained from the upper respiratory tract and from the eye
whereas their protein was neither detected by immunohistochemistry nor by immunoblotting
in these tissues. Quantitative RT-PCR revealed that jejunal and colonic expression levels of
CLCA4bmRNA in mutant pigs were approximately half (jejunum) and one third (colon) of its
expression in wild type pigs (Fig 4B). In correlation to the findings by immunohistochemistry,
heterozygous pigs showed similar expression levels in the jejunum as compared to wild type,
whereas the CLCA4b expression in the colon was approximately three times lower compared
to wild type pigs.
CLCA4b does not evoke a calcium-dependent chloride conductance in
HEK293 cells
Whole-cell recordings were obtained from CLCA4b-expressing HEK293 cells as confirmed by
EGFP or RFP fluorescence (Fig 5). Shortly after application of the calcium ionophore ionomy-
cin (10 μM), we observed a slowly-developing inward current. In cells transfected with cDNA
coding for CLCA4b (wt) or CLCA4b (mut), this current reversed near the estimated equilib-
rium potential for calcium (Ca2+) (CLCA4b wt: +47 ± 6 mV, n = 10; CLCA4b mut: +52 ± 12
mV, n = 13; Fig 5C and 5D). In HEK cells transfected with EGFP alone, the ionomycin-evoked
current reversed at +35 ± 6 mV (n = 8) which did not differ significantly from CLCA4b (wt)-
or CLCA4b (mut)-transfected cells (p> 0.05). The inward current under these conditions is
likely the result of the Ca2+ conductance created by insertion of the ionomycin ionophore into
the membrane, suggesting that elevated intracellular [Ca2+] did not trigger a chloride (Cl-) con-
ductance in cells expressing CLCA4b (wt), CLCA4b (mut) or EGFP alone. In contrast, we suc-
cessfully recorded ionomycin-evoked anion currents in cells transfected with cDNA for
CLCA1, a member of the CLCA family known to induce a calcium-activated chloride conduc-
tance [32]. As with cells transfected with CLCA4b (wt) or CLCA4b (mut), application of iono-
mycin was followed by an inward current, however, this current reversed at 11 ± 6 mV (n = 8;
Fig 5D) and developed more quickly. This reversal potential was significantly less positive than
that for CLCA4b (wt) (p<0.005, independent t-test) or for CLCA4b (mut) (p<0.01, indepen-
dent t-test), and fell between the equilibrium potentials for Ca2+ and Cl-, suggesting that ele-
vated intracellular [Ca2+] triggered a Cl- conductance in cells expressing the equine CLCA1,
consistent with its previous characterization [34].
Discussion
The recently available CF pigs are regarded as the most suitable animal models because they
mimic the human disease much more closely than the murine models do [22–27]. Members of
the CLCA gene family, particularly CLCA1 and CLCA4, have been shown to modulate several
aspects of the human CF phenotype [1,3,4]. Interestingly, significant differences have been
described between several human CLCA and their orthologous murine genes and proteins,
suggesting further difficulties in translating phenotypical features of murine CF models to the
human disease. For example, the human CLCA gene locus consists of only four genes, whereas
the murine gene locus consists of eight genes [20] and the human CLCA3 is thought to be a
pseudogene whereas its murine orthologs are not [21]. Furthermore, the cellular expression
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pattern of the human CLCA4 is quite different from that of its murine ortholog [17]. Thus,
with the generation of CF pig models, the porcine CLCA genes and proteins have become a
focus of interest in terms of potentially CF-relevant differences to their human orthologs. Spe-
cifically, we have started to systematically characterize the genetic structure, tissue and cellular
Fig 5. CLCA4b does not evoke a calcium-dependent chloride current characteristic of otherCLCA
family members. (A) Currents were evoked in HEK293 cells expressing CLCA4b (wt) by a series of voltage
steps (150 ms, -110 to -10 mV) before (left) and after (right) application of the calcium ionophore ionomycin
(10 μM). Ionomycin stimulated an inward current at the holding potential of -50 mV and increased the
amplitude of step-evoked currents. (B) Similar experiment for HEK293 cells expressing CLCA4b (mut). In A
and B, zero current is indicated by the dotted lines. (C) Current-voltage relationship for the difference currents
were obtained by subtracting the step-evoked currents before from those after ionomycin application. Linear
extrapolation was used to determine the reversal potential (Erev) for the ionomycin-stimulated currents which
were normalized to the current at the holding potential (-50 mV). (D) Mean Erev for ionomycin-stimulated
currents in cells expressing CLCA4b (wt) (n = 10), CLCA4b (mut) (n = 13), CLCA1 (n = 8), serving as a
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expression patterns of their porcine CLCA homologs to evaluate their relevance for the pheno-
type in the CF pig models [28–30].
Unlike in any other mammalian species tested so far, the CLCA4 gene has undergone a
duplication in the pig resulting in an additional gene which we termed CLCA4b, located
between the parental CLCA4a and the CLCA3 genes on chromosome 4 [28–30]. The results of
this study suggest that this apparently pig-specific gene is transcribed into a full length protein
with several hallmark characteristics of other CLCA proteins, including its length of 921 amino
acids, a conserved amino domain which is thought to function as a metalloprotease [35], the
van Willebrand-factor A domain, a domain of unknown function and a predicted single trans-
membrane domain. Of note, our bioinformatic analyses strongly argue for evolutionary pres-
sure and functional adaptation of the protein.
Among the most relevant results is the obviously highly cell-type specific expression pattern
of the CLCA4b protein which is different from that of CLCA4a and also from that of any other
CLCA proteins in the pig and other species investigated so far. While CLCA4a is selectively
expressed at the apical membranes of enterocytes at the villus tips in the small and large intes-
tine [29], its duplication product CLCA4b was only found at the apical membrane of small and
large intestinal crypt epithelial cells. The functional consequence of this separation remains
elusive so far.
Similar to its parental gene product CLCA4a [28], CLCA4b covers a broader tissue expres-
sion pattern on mRNA than on protein level which has also been reported for other CLCA
members, such as the murine Clca2, formerly known as mClca5 [35]. It is unknown to date
whether tissue specific posttranscriptional regulatory events preventing protein synthesis or a
tissue-dependent low and therefore immunohistochemically undetectable protein level may
account for this observation.
Interestingly, the murine Clca4a protein, formerly termed mClca6, is expressed in entero-
cytes both at the villous tips and deep crypts [17], arguing that both microenvironments are
served by the same Clca protein in mice. The duplication of the two porcine CLCA4 genes and
the cellular expression of their products in the same tissue environment (Fig 6) thus support
the notion of species-specific divergences of CLCA genes which has previously been observed
in other species and for other members of the CLCA family of proteins [36]. Whether the
change of expressing cell type goes along with a similar or changed protein function or regula-
tory pathways will have to be established in the future. A second obvious difference between
the pig CLCA4a and CLCA4b genes and the mouse Clca4 ortholog clearly lies in their different
expressions in the respiratory tract: while the porcine CLCA4a was convincingly detected at
the apical membranes of tracheal and bronchial epithelial cells [28], neither the duplicated
CLCA4b protein nor the mouse CLCA4 orthologous proteins [17] were found to be expressed
in the trachea or lungs. Details on the cellular expression of the human CLCA4 protein have
not yet been reported and await further studies. The porcine CLCA1 is another CLCA protein
expressed in the intestine which, however, has been found in mucus-producing goblet cells
only but not in non-goblet cell enterocytes [27]. The close proximity of the two CLCA4 vari-
ants in pigs to this third CLCA protein further supports the notion of different CLCA members
covering different cellular and probably functional niches in the intestine [17] (Fig 6).
Several members of the CLCA family in pigs and in other species are capable of modulating
calcium-activated anion conductances in vitro [36], and the cellular expression patterns on the
apical membrane of intestinal (CLCA4a and -b) and respiratory cells (CLCA4a only) support
the proposed role in transepithelial anion conductance [29]. Recently, the chloride channel
protein TMEM16A has been identified as a molecular target of CLCA1 [16]. Alternative chlo-
ride currents which are not mediated by CFTR have been proposed to possibly compensate for
the defective chloride secretion in CF patients and are considered promising therapeutic targets
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[8–10]. In humans, the CLCA1/CLCA4 gene locus acts as a modifier of rectal anion conduc-
tance of CF patients and allelic variants of both CLCA1 and CLCA4 are associated with the
severity of intestinal phenotype or the capability to express residual chloride secretion in the
colon epithelium, respectively [1,3,4]. Consistently, the murine ortholog to hCLCA4 induces a
calcium-activated chloride conductance [18]. Surprisingly, in our study the porcine CLCA4b
was unable to evoke a calcium-activated chloride current in vitro in this study.
In light of its role as modulator of the CF phenotype in humans [1,3,4], it appears notewor-
thy that only the porcine CLCA4b but not CLCA4a is expressed by the same crypt epithelial
cells that also express the CFTR protein (Fig 6) [33]. Both the separation into the two gene
products CLCA4a and CLCA4b in pigs only with an as yet unknown functional significance
and the observation that a large percentage of pigs harbors a complete deletion of the CLCA4b
protein expression give ample reason to assume that its alleged modulatory role may differ
between pig models of CF on one side and mouse and human CF on the other. A detailed char-
acterization of the functions of the CLCA4 variants and the consequence of the complete loss
of CLCA4b in the context of the three available pig models of CF [22,23,26] will realistically be
required before the CF phenotype in pigs can be fully interpreted to better understand the
human disease. In contrast to the situation in humans with 15% of CF neonates developing
meconium ileus, 100% of CF piglets present this lesion, along with an overall worse intestinal
phenotype [22,23,26]. It will be interesting to explore whether the porcine-specific CLCA4
Fig 6. The porcineCLCA proteinsCLCA1, CLCA4a andCLCA4b occupy different cellular niches in the
intestinal tract. The CLCA4a protein (blue) had previously been detected exclusively in small intestinal villus
enterocytes. In contrast, its paralog CLCA4b (orange) is expressed only in small and large intestinal crypt
epithelial cells where the porcine CFTR protein (green) is also expressed. Moreover, a third CLCA protein,
the fully secreted CLCA1 (brown) is expressed by goblet cells. Thus, each porcine CLCA protein appears to
occupy a distinct functional niche in small and large intestine. Interestingly, the combination of CLCA4a (blue)
and CLCA4b (orange) represent the expression pattern of their single murine ortholog CLCA4a (compare
Bothe et al. 2008). G = goblet cell, NG = non-goblet enterocyte.
doi:10.1371/journal.pone.0140050.g006
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variants or the mutation of CLCA4b have an impact on this striking intestinal phenotype in
pigs and may contribute to this noteworthy difference to human CF.
In addition to their well-established induction of ion conductance, some CLCA proteins
have functionally been linked to the induction of expression of mucus genes [20] or cytokines
[37,38] as well as cellular differentiation [39,40]. The human CLCA4 protein, for example,
seems to a play a role in epithelial differentiation since its loss promotes epithelial-to-mesen-
chymal transition in vitro [40]. Thus, the unique cellular expression pattern of CLCA4b in
crypt epithelial cells raises the question of whether it may serve a related function in cellular
differentiation processes since crypts are the niche of stem cells for intestinal epithelial cell
renewal and differentiation.
In this study, we revealed a unique CLCA4b gene mutation resulting in complete loss of the
protein in a remarkably large subpopulation of pigs. The 10 bp deletion causes alternative splic-
ing, generating distinct transcripts of the CLCA4b mRNA which invariably result in a prema-
ture termination codon as result of a frameshift mutation. It is plausible that nonsense-
mediated decay [41–43] prevented the synthesis of a truncated, putatively nonfunctional pro-
tein, an assumption that was well confirmed when we failed to detect any truncated protein in
immunoblot analysis of HEK293 cells transfected with the mutated form of CLCA4b.
In our test cohort of more than 100 pigs, one or two mutated and thus non-functional alleles
were found in ancient as well as modern pig breeds. Although we failed to observe any clinical
or histological phenotype in the affected animals, this does not necessarily mean that the gene
function is ultimately dispensable for pigs, as a specific phenotype might only appear under
specific challenges. The high prevalence of the mutation in all pig breeds tested suggests that
the mutation has occurred before modern pig breeds arose or that the mutation has been dis-
tributed among pig breeds by systematic cross-mating. The latter might, in turn, imply that the
mutation of CLCA4b (or a yet undefined allele variant in close vicinity to the CLCA4b gene)
has a selective advantage over the wild type form that resulted in a preferential selection for
breeding purposes. Although the biological basis for such an evolutionary trait is completely
unclear, this is not untypical for the evolution of lifestock animals and it is also in correlation
to genetic defects in human beings, where heterozygous carriers of sickle cell anemia alleles
have a selective advantage in regions with persistent malaria infections. Also, the expansion of
mutated CFTR alleles in the human population have been repeatedly considered as a result of
the higher resistance of heterozygous carriers to secretory diarrhea when intestinal pandemies
caused major losses on the central European population in the Middle Ages [44]. Additionally,
the natural knockouts and possibly even the heterozygous carriers may serve as models to
study the actual function of the CLCA4 protein and the pathways it is involved in, similar to
the use of experimental mouse knockout models in terms of a functional genomics approach.
In summary, the pig-specific duplication of the CLCA4 gene results in two functional pro-
teins, CLCA4a and CLCA4b, which have segregated into two adjacent cellular niches, i.e. the
intestinal epithelial cells at the villous tips versus those deep in the crypts. In the mouse and
likely other mammalian species, both cell types express the protein product of the unduplicated
parent Clca4 gene. The functions of the two CLCA4 protein variants in pigs and the biomedical
consequences of their separation, specifically in terms of their alleged modulatory role in CF,
remain to be established. Surprisingly, a CLCA4b gene mutation resulting in the complete loss
of protein expression in homozygously affected animals is persistent in the pig population.
This mutation seems to have no impact on any phenotype at first sight. These CLCA4b-specific
features will have to be considered in future studies using any of the pig models of CF, specifi-
cally in light of the putative modulatory role of CLCA4 in CF.
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